Registered entities
Stoke Therapeutics, Inc
Reg. No. 47-1144582United States
Stoke Therapeutics, Inc.
Reg. No. 1623526United States
Innovation
35 patent families (9 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace steady. Cited 8,960 times.
| Year | Filings |
|---|---|
| 2017 | 9 |
| 2018 | 9 |
| 2019 | 13 |
| 2020 | 5 |
| 2021 | 12 |
| 2022 | 16 |
| 2023 | 13 |
| 2024 | 18 |
| 2025 | 19 |
| 2026 | 8 |
Social engagement
Social engagement: 21.3K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
7 investors on record; lead investors include Apple Tree Partners, RTW Investments.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 57% |
| Other / undisclosed | 3 | 43% |
Hiring activity
Hires occasionally
1 role tracked across 1 of the last 12 months
10 Jun 2026 · Director, Strategic Purchasing · Waltham
14 Aug 2025 · Senior Director, Market Access Strategy & Marketing New Bedford, Massachusetts, · Brockton
30 May 2025 · Manager, Information Security · New Bedford
30 May 2025 · Clinical Trial Manager, Clinical Operations · New Bedford
Based on job postings tracked across public sources.
Recent activity
30 Jun 2026
Milestone
regulatory
29 Jun 2026
Recognition
25 Jun 2026
Event
2026 DSF Family & Professional Conference